tiprankstipranks
MiNK Therapeutics (INKT)
NASDAQ:INKT
US Market
INKT
MiNK Therapeutics
RESEARCH TOOLSreports
Want to see INKT full AI Analyst Report?

MiNK Therapeutics (INKT) Stock News & Sentiment

264 Followers
Mink Therapeutics’ Earnings Call: High Promise, Tight Runway
Premium
Company Announcements
Mink Therapeutics’ Earnings Call: High Promise, Tight Runway
6d ago
INKT
Buy Rating on MiNK Therapeutics Driven by Promising Phase 2 Survival Benefit and Immune Activation in PD-1–Refractory Gastric Cancer
Premium
Ratings
Buy Rating on MiNK Therapeutics Driven by Promising Phase 2 Survival Benefit and Immune Activation in PD-1–Refractory Gastric Cancer
28d ago
INKT
MiNK Therapeutics: Buy Rating on Emerging Pulmonary Franchise and Key agenT-797 ARDS Catalyst
Premium
Ratings
MiNK Therapeutics: Buy Rating on Emerging Pulmonary Franchise and Key agenT-797 ARDS Catalyst
2M ago
INKT
MiNK Therapeutics’ Earnings Call Signals High-Risk Upside
Premium
Company Announcements
MiNK Therapeutics’ Earnings Call Signals High-Risk Upside
2M ago
INKT
INKT Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
INKT Upcoming Earnings Report: What to Expect?
2M ago
INKT
MiNK Therapeutics Explores Strategic Partnerships and Trial Collaborations
Premium
Company Announcements
MiNK Therapeutics Explores Strategic Partnerships and Trial Collaborations
2M ago
8K
INKT
MiNK Therapeutics Appoints New Principal Financial and Accounting Officers
Premium
Company Announcements
MiNK Therapeutics Appoints New Principal Financial and Accounting Officers
2M ago
8K
INKT
More INKT News >

INKT News on the Web

Analysts Are Bullish on These Healthcare Stocks: Biofrontera (BFRI), MiNK Therapeutics (INKT)
TipRanks News
Bullish
Mink Therapeutics’ Earnings Call: High Promise, Tight Runway
TipRanks News
Bullish
MiNK Therapeutics Inc (INKT) Q1 2026 Earnings Call Highlights: Strategic Advances and Financial ...
GuruFocus News
Neutral
MiNK Therapeutics (INKT) Reports Positive Developments in Q1 2026 Earnings Call
GuruFocus News
Bullish
Q1 2026 Mink Therapeutics Inc Earnings Call Transcript
GuruFocus News
Neutral
MiNK Therapeutics Q1 Earnings Call Highlights
MarketBeat
Bullish
Is MiNK Therapeutics (INKT) Fairly Valued After Q1 2026 EPS Beat? EPS -0.57 vs -0. ...
GuruFocus News
Neutral
MiNK Therapeutics initiates agenT-797 clinical trial
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
INKT
Sector Average
Media Buzz
This Week8 articles
Weekly Average0.75 articles
News Sentiment
This Week100%
Sector Average76%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is INKT’s Media Buzz Sentiment?
8 articles about INKT were published this week. In an average week, 0.75 articles are published.
    What is INKT’s weekly average amount of articles?
    In an average week, 0.75 articles about INKT are published.
      What is INKT’s News Sentiment?
      100% of articles about INKT were positive this week, compared to its sector average of 76%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        IMVTImmunovant
        ROIVRoivant Sciences
        PROKProKidney
        Showing the stocks with the most bullish news sentiment over the past week